Paid Clinical Trials in Kalamazoo, MI
As of June 2026, 106 paid clinical trials are recruiting in Kalamazoo, Michigan. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Kalamazoo offers studies at sites including Bronson Methodist Hospital for conditions such as Malignant Solid Neoplasm, Anatomic Stage II Breast Cancer AJCC v8, B Acute Lymphoblastic Leukemia, Lung Non-Small Cell Carcinoma. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Kalamazoo
Filter results
0 clinical trials
·Clear filters·↓ Download CSVAbout research studies in Kalamazoo
Kalamazoo has approximately 106 recruiting research studies across a wide range of therapeutic areas. Michigan hosts University of Michigan Health, Henry Ford Health, and Corewell Health, running trials across oncology, neurology, and cardiology with a strong focus on precision medicine.
Top Research Study Locations in Kalamazoo
Researchers run research studies in Kalamazoo, MI at 21 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Bronson Methodist Hospital | Malignant Solid Neoplasm, Anatomic Stage II Breast Cancer AJCC v8, B Acute Lymphoblastic Leukemia | 76 |
| West Michigan Cancer Center | Malignant Solid Neoplasm, Anatomic Stage II Breast Cancer AJCC v8, Lung Non-Small Cell Carcinoma | 73 |
| Beacon Kalamazoo | Malignant Solid Neoplasm, Anatomic Stage IV Breast Cancer AJCC v8, Breast Cancer | 36 |
| Beacon Kalamazoo Cancer Center | Malignant Solid Neoplasm, Recurrent Endometrial Carcinoma, Anatomic Stage I Breast Cancer AJCC v8 | 36 |
| Borgess Medical Center | Metastatic Malignant Neoplasm in the Brain, Acral Lentiginous Melanoma, Anatomic Stage IV Breast Cancer AJCC v8 | 6 |
| Ascension Borgess Cancer Center | Acral Lentiginous Melanoma, Anatomic Stage IV Breast Cancer AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8 | 5 |
| Western Michigan University | Cardiovascular Disease and Lipoprotein(a), Diabetes, Healthy | 3 |
| InterAct of Michigan | First Episode Psychosis | 2 |
| Wellnow Urgent Care and Research | Acute Treatment of Migraine, Pediatric Migraine | 2 |
| Ascension Borgess Hospital | Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm, Metastatic Malignant Solid Neoplasm | 1 |
| Bronson Methodist Hospital/Western Michigan University Homer Stryker M.D. School of Medicine | Acute Ischemic Stroke | 1 |
| Corxel Investigational Site | Acute Ischemic Stroke | 1 |
| Local Institution - 162 | Schizophrenia | 1 |
| Nephrology Center, PC | Chronic Kidney Diseases, Type 2 Diabetes Mellitus | 1 |
| Paragon Health Nephrology Center - Kalamazoo | Focal Segmental Glomerulosclerosis | 1 |
| Paragon Health, Inc | Atherosclerotic Cardiovascular Disease, Atherosclerotic Cardiovascular Disease in Patients With ESKD, End Stage Kidney Disease | 1 |
| Planned Parenthood - Kalamazoo | Pregnancy | 1 |
| WMU Homer Stryker MD School of Medicine | Acute Myocardial Infarction (AMI), Cardiovascular Risk | 1 |
| WMed Health Family Medicine - Crosstown Parkway | Chronic Condition, Chronic Conditions, Multiple, Chronic Disease | 1 |
| West Michigan Cancer Centre | Cutaneous Melanoma, Stage II | 1 |
| Western Michigan Univ. Homer Stryker M.D. School of Medicine | Aortic Valve Disease, Aortic Valve Stenosis, Heart Disease Structural Disorder | 1 |
Active & Upcoming Studies in Kalamazoo (2026)
Recruiting trials in Kalamazoo grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (69 active studies)
- Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations · Phase 3 · SWOG Cancer Research Network
- Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays · Alliance for Clinical Trials in Oncology
Neurology & pain (5 active studies)
- Optimizing Reperfusion to Improve Outcomes and Neurologic Function · Phase 2, Phase 3 · Corxel Pharmaceuticals
- Haloperidol for Pain Control in Patients With Acute Musculoskeletal Back Pain in the Emergency Department · Phase 4 · Western Michigan University School of Medicine
Diabetes & metabolic (2 active studies)
- Transcutaneous Electrical Stimulation and Controlled Heat in People With and Without Diabetes · Western Michigan University
- Proact: A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease · Phase 3 · Prokidney
Cardiovascular (2 active studies)
- ENVISION IDE Trial: Safety and Effectiveness of NAVITOR in Transcatheter Aortic Valve Implantation · Abbott Medical Devices
- Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS · Phase 3 · DalCor Pharmaceuticals
Mental health & behavior (1 active study)
- An Extension Study to Assess Long-Term Safety and Tolerability of Adjunctive KarXT in Subjects With Inadequately Controlled Symptoms of Schizophrenia · Phase 3 · Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Pediatric (1 active study)
- Randomized Study in Children and Adolescents With Migraine: Acute Treatment · Phase 3 · Pfizer
Common conditions studied in Kalamazoo
- Malignant Solid Neoplasm (6 active studies). Recruiting Malignant Solid Neoplasm studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Anatomic Stage II Breast Cancer AJCC v8 (4 active studies). Breast cancer trials evaluate new hormone therapies, targeted drugs, and immunotherapy combinations aimed at improving survival and reducing recurrence.
- B Acute Lymphoblastic Leukemia (4 active studies). Leukemia trials evaluate targeted inhibitors, CAR-T cell therapies, and novel combinations for acute and chronic forms of the disease.
- Lung Non-Small Cell Carcinoma (4 active studies). Recruiting Lung Non-Small Cell Carcinoma studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Acute Myeloid Leukemia (3 active studies). Leukemia trials evaluate targeted inhibitors, CAR-T cell therapies, and novel combinations for acute and chronic forms of the disease.
- Advanced Lung Non-Small Cell Carcinoma (3 active studies). Recruiting Advanced Lung Non-Small Cell Carcinoma studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
Leading research sponsors in Kalamazoo
- National Cancer Institute (NCI)
- SWOG Cancer Research Network
- Children's Oncology Group
- NRG Oncology
- ECOG-ACRIN Cancer Research Group
Local regulations and guidelines
Clinical trials in Michigan are governed by U.S. Food and Drug Administration (FDA) regulations, Office for Human Research Protections (OHRP) standards, and federal HIPAA privacy rules. Every study is reviewed by an Institutional Review Board (IRB) to protect participant safety and ensure informed consent. Michigan research additionally follows state public health department oversight and any applicable state privacy statutes.
Compensation & what to expect
- How payment typically works
- Compensation is most often provided through reloadable electronic study cards or direct deposit, paid out per completed visit rather than as a lump sum. Amounts vary by the time required, the number of visits, and the study's complexity — overnight stays and inpatient pharmacology studies generally pay more than short outpatient surveys. The exact amount is disclosed in writing during informed consent before any visit.
- Healthy volunteers
- Healthy participants aged 18 and older can earn compensation by joining vaccine, pharmacology, and biomarker studies in Kalamazoo. These trials check how a new drug or vaccine behaves in healthy bodies before later-phase testing. Many sites maintain a healthy-volunteer registry so you hear about new opportunities first.
- What's included beyond payment
- Most trials cover study-related medical care at no cost — physical exams, lab work, imaging, the investigational treatment itself, and follow-up visits with the research team. Insurance is not required to participate. Free check-ups and access to specialists are common reasons participants return for additional studies.
- Travel and time
- Many sponsors reimburse travel, parking, mileage, and lost wages for visit days. Long-running studies and trials that require frequent visits often raise stipends accordingly. Ask the study coordinator for the visit schedule and reimbursement policy before you commit.
- Asking about compensation
- Compensation is set per protocol and per site, so figures are not published in trial registries. The fastest way to confirm payment for a specific study is to contact the recruiting site listed on the study record. Coordinators are accustomed to this question and will quote the per-visit and total amounts up front.
How to find a clinical trial in Kalamazoo
Hipa.ai aggregates every recruiting study in Kalamazoo from ClinicalTrials.gov and refreshes the list daily. Use the filters above to narrow by condition, facility, age, phase, or healthy-volunteer eligibility, then click any study title to view full details — eligibility criteria, intervention, location, and sponsor contact information. To enroll, reach out to the central study contact listed on the study detail page; the research coordinator will walk you through the screening process.
Frequently asked questions
How many paid clinical trials are currently recruiting in Kalamazoo?
There are approximately 106 recruiting clinical trials in Kalamazoo, Michigan listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Kalamazoo pay participants?
Most recruiting trials in Kalamazoo compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Kalamazoo?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Kalamazoo?
The most common conditions under active study in Kalamazoo include Malignant Solid Neoplasm (6), Anatomic Stage II Breast Cancer AJCC v8 (4), B Acute Lymphoblastic Leukemia (4), Lung Non-Small Cell Carcinoma (4), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Kalamazoo?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Kalamazoo on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Kalamazoo?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Kalamazoo?
Recruiting research sites in Kalamazoo include Bronson Methodist Hospital, West Michigan Cancer Center, Beacon Kalamazoo, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Kalamazoo right now?
The largest active categories in Kalamazoo are Cancer & tumors (69), Neurology & pain (5), Diabetes & metabolic (2). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.